Skip to content

Bemethyl

Also called Bemitil — 2-ethylthiobenzimidazole

A Russian 'actinoprotector'.

  • TypeBioregulator
  • FormOral
  • Researched forPerformance & Endurance
Join Skool for the protocol

No partner carries Bemethyl yet.

The short version

  • What the evidence isRussian and Soviet clinical literature, where it is classed as an 'actinoprotector' — a drug category that essentially does not exist outside that research tradition.
  • What to watchPersistent insomnia or edginess.

How Bemethyl works

A Russian 'actinoprotector' — the drug class built around improving tolerance to physical work under hypoxia. Its described action is on mitochondrial protein synthesis: rather than stimulating output acutely like a beta-agonist, it is reported to raise the enzymatic capacity for gluconeogenesis and aerobic metabolism over a course of days.

Bemethyl is 2-ethylthiobenzimidazole, usually supplied as the hydrobromide salt, and the sulfur atom is the whole molecule. A benzimidazole ring with an ethylthio group at position 2: a small, lipophilic, weakly basic heterocycle of about 178 Da as the free base.

It belongs to a drug class that has no equivalent outside the Russian-language literature. An actoprotector is defined by what it is supposed to do: maintain physical work capacity under hypoxia without stimulating the central nervous system. Oliynyk 2012 is the English-language review of the class and it is the right place to start, because the framing matters: this is not a stimulant, and a page that treats it as one has already made the central error.

  • Oral

On the goal map: Exercise mimetics & mitochondrial biogenesis (Endurance & work capacity)

Where to get Bemethyl

No partner carries it yet.

When a vetted partner does, the link and code go here.

Research on Bemethyl5 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Human (Russian/Soviet clinical literature); almost none of it replicated outside that school.

Human clinical evidence

  • Russian and Soviet clinical literature, where it is classed as an 'actinoprotector' — a drug category that essentially does not exist outside that research tradition. Studied for physical work capacity, hypoxia tolerance and recovery.

  • Almost none of it has been replicated independently. Single-group designs, one research school, one language. See [[evidence-framing-rule]] — that is an absence of evidence, not evidence of absence, and the two get confused constantly with this class.

Correlative data

  • It sits in the same evidence position as the Khavinson bioregulators already in the Vault: decades of use inside one system, and a near-total gap in the Western literature. Read it the same way.

How the mechanism reads

  • Described as acting on mitochondrial protein synthesis — raising the enzymatic capacity for gluconeogenesis and aerobic metabolism rather than stimulating output acutely.

    Mechanistic
  • If the mechanism is adaptive rather than stimulant.

    Mechanistic

Sources

  • Belinskaia DA, et al. Investigation of Bemethyl Biotransformation Pathways by Combination of LC-MS/HRMS and In Silico Methods. International Journal of Molecular Sciences 2021 · PMID 34445727
  • Oliynyk S, Oh S. The pharmacology of actoprotectors: practical application for improvement of mental and physical performance. Biomolecules and Therapeutics 2012 · PMID 24009833
  • Kibal'chich DA, et al. [Pharmacokinetics of domestic actoprotector drug Metaprot in healthy volunteers]. Eksperimentalnaia i Klinicheskaia Farmakologiia 2011 · PMID 21870773
  • Boiko SS, et al. [Bemetil pharmacokinetics in an experiment on rats]. Farmakologiia i Toksikologiia 1987 · PMID 3691781
  • Kobylianskii VI, et al. [Effect of bemithyl (bemactor) on the bronchial epithelium regeneration and the main protector mechanisms of the respiratory system in chronic inflammation]. Tsitologiia 1999 · PMID 10420471
  • Lobzin VS, et al. [The use of bemitil in patients with progressive muscular dystrophies]. Likars'ka Sprava 1992 · PMID 1441389

Bemethyl safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Liver disease, because clearance runs through glutathione-linked pathways.
  • Insomnia or an anxiety disorder, as the compound is mildly activating.
  • Pregnancy, with no Western safety work on file.
  • Under 18, because this actoprotector was only studied in adult workers and athletes.

What’s expected

  • More tolerance to physical work in low oxygen, per Russian actoprotector studies.
  • A mild stimulating feel without a beta-agonist style spike.
  • Headache in some users.

Watch for

  • Persistent insomnia or edginess.
  • Nausea with upper abdominal pain.
  • Yellowing of the skin or eyes.

Labs that tell you it’s working

  • Comprehensive Metabolic Panel: liver enzymes, because glutathione-dependent clearance is the burden.
  • Cortisol: actoprotectors are reported to blunt the stress-axis response, so this tests the claim.

Russian actoprotector described as raising mitochondrial and ribosomal protein synthesis under hypoxic stress; Western toxicology is thin. PMID 24009833

Bloodwork to runHow you would know it is working: 8 tests in one order, code CAMERON

Bemethyl FAQ3 common questions

Is Bemethyl approved for human use?
No. Bemethyl is a research compound.
Which labs show whether it's doing anything?
Comprehensive Metabolic Panel; Cortisol: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Bemethyl: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Bemethyl is. Skool covers how it is run.

Free on this page

What Bemethyl is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Bemethyl is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Join Skool for the protocol